ChromaDex Partners with Juvenis for Cross-Border Sales of Tru Niagen® into South Korea
ChromaDex Corp. (NASDAQ:CDXC) today announced a partnership with Juvenis to conduct cross-border sales of Tru Niagen in South Korea.
- ChromaDex Corp. (NASDAQ:CDXC) today announced a partnership with Juvenis to conduct cross-border sales of Tru Niagen in South Korea.
- Tru Niagen is one of Amazons top-selling brands in the Vitamin B3 category for boosting NAD+ levels and features ChromaDexs proprietary ingredient, Niagen (patented nicotinamide riboside or NR).
- It is our goal to provide global access to Tru Niagen and are thrilled to partner with Juvenis to bring its proven benefits to South Korea, said Frank Jaksch, Co-Founder and Executive Chairman of ChromaDex.
- We are pleased to execute a partnership with ChromaDex for the South Korean market, said Dongyeon Kim, CEO of Juvenis.